Prescribing M&A to cure valuations
Biotech Growth Trust* (BIOG) aims to deliver capital appreciation through investment in the global Biotechnology Sector. The fund was launched in 1997 and has been managed by Geoffrey Hsu of specialist investment adviser OrbiMed since May 2005. We attended an analyst meeting with Geoffrey Hsu on 1 March 2023.
*Denotes a corporate broking client of Winterflood Securities